Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Abivax Sa ADR (ABVX)

Abivax Sa ADR (ABVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abivax Sa ADR 7 BD HAUSSMANN PARIS I0 75009 FRA

www.abivax.com Employees: 69 P: 33-01-53-83-09-63

Sector:

Medical

Description:

Abivax SA is a clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax SA is based in PARIS, FRANCE.

Key Statistics

Overview:

Market Capitalization, $K 9,322,285
Enterprise Value, $K 9,245,025
Shares Outstanding, K 78,444
Float, K 78,444
% Float 100.00%
Short Interest, K 2,909
Short Float 3.71%
Days to Cover 1.67
Short Volume Ratio 0.33
% of Institutional Shareholders 47.91%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -190,710 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -179,260 K
EBIT, $ -196,850 K
EBITDA, $ -195,660 K

Growth:

1-Year Return 1,783.99%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.45 on 12/15/25
Next Earnings Date 03/23/26
Earnings Per Share ttm -4.18
EPS Growth vs. Prev Qtr -184.88%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

ABVX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % 0.00%
Debt/Equity 0.08
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 15.25
Book Value/Share 7.68
Interest Coverage -9.37
60-Month Beta 0.68
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar